AeroVironment Restates Q3 2026 Financials, Discloses Material Weakness in Internal Controls
AVAV is trading near its 52-week low of $156 (5.1% above the low).
Summary
AeroVironment Inc. restated its Q3 2026 financials, revealing an $87.3 million understatement of net loss and a material weakness in internal controls, following a significant goodwill impairment.
Key Events · Corporate Governance and Compliance · AVAV
-
Financial Restatement
Net loss for the nine months ended January 31, 2026, was understated by $87.272 million, and basic/diluted EPS was understated by $1.79. This restatement follows a prior 8-K announcement on 2026-06-22.
-
Material Weakness in Internal Controls
The company identified a new material weakness in its internal control over financial reporting, specifically related to the preparation and review of goodwill impairment analysis, rendering disclosure controls ineffective.
-
Significant Goodwill Impairment
The restatement includes a goodwill impairment charge of approximately $241 million in the Space reporting unit. This was triggered by a stop-work order on the BADGER phased array antenna systems program.
Analysis · AVAV · Manufacturing
AeroVironment Inc. filed an amended quarterly report (10-Q/A) to restate its financial statements for the three and nine months ended January 31, 2026. The restatement corrected an error that understated net loss by $87.272 million and basic/diluted EPS by $1.79 for the nine-month period. This error stemmed from a newly identified material weakness in internal control over financial reporting related to the goodwill impairment analysis for its Space reporting unit. The restatement also includes a significant goodwill impairment charge of approximately $241 million, triggered by a stop-work order on a key defense program. This indicates significant financial reporting issues and operational challenges in a key segment.
At the time of this filing, AVAV was trading at $164.03 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $8.5B. The 52-week trading range was $156.00 to $417.86. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.